New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
8 trends tracked about this subject — the full history, oldest to newest below.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Pancreatic cancer specialists are focusing on the new drug daraxonrasib as multiple hospitals join a national initiative.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A mutant KRAS vaccine yields early positive results in its first human clinical trial for high-risk pancreatic cancer patients.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A Johns Hopkins-developed KRAS vaccine has demonstrated safety and durable immune responses in a trial focused on preventing pancreatic cancer in high-risk individuals.
The European Medicines Agency has fast-tracked the review of an experimental pancreatic cancer pill amid reports of significant clinical trial outcomes.